DayTwo is a precision medicine company that uses food as medicine to enable a path to remission for metabolic disease: diabetes, prediabetes, clinical obesity, NAFLD. DayTwo's groundbreaking scientific discovery, published in CELL (2015) and JAMA (2019) determined that people respond differently to the same food, thus knowing what food “works” for each person is crucial to an effective care plan. DayTwo uses gut microbiome sequencing (stool sample, akin to Cologuard) to create Food Prescriptions for each patient, to balance blood sugar levels, improve energy, manage hunger, and lose weight. The DayTwo Telehealth solution is delivered through Certified Diabetes Care and Education Specialists and Registered Dietitians using a digital app to track progress and to communicate with members. DayTwo uses A1C and Time In Range as the primary clinical outcomes, and weight as a secondary outcome. For those who implement the DayTwo protocol, DayTwo offers up to 100% fees-at-risk.
Something looks off?